RxSight Inc. (RXST)
RxSight Max Pain By Strike
RXST trades at $8.8, 12.0% below the near-term max pain of $10 expiring Oct 17, 2025 (13 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is rising across expirations ($2.5-$10), reflecting growing call interest at higher strikes. Key magnetic zone at 10 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
RxSight Max Pain By Expiry
Max pain for RXST shows an upward trend from 2.5 to 10, suggesting bullish positioning in longer-dated options. The 107% spread signals divergent expectations across timeframes. Levels distributed around 8.8. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Oct 17, 2025 | 10 | n/a (n/a) |
| Nov 21, 2025 | 2.5 | n/a (n/a) |
| Dec 19, 2025 | 10 | n/a (n/a) |
| Jan 16, 2026 | 7.5 | n/a (n/a) |
| Mar 20, 2026 | 5 | n/a (n/a) |